• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Center for Biologics Evaluation and Research Strategic Plan FY 2012-2016: Innovative Technology Adavancing Public Health
【24h】

Center for Biologics Evaluation and Research Strategic Plan FY 2012-2016: Innovative Technology Adavancing Public Health

机译：2012-2016财年生物制品评估与研究战略计划中心：创新技术促进公共卫生

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

CBERs strategic plan is based on our mission and vision and identifies our strategic goals, and related objectives and strategies. Our plan is aligned with the FDA Strategic Priorities document and the Department of Health and Human Services strategic plan. CBERs plan reflects the contributions of all offices and divisions, and it sets forth the Centers four overarching program goals and two cross-cutting goals: Goal 1: Increase the nation's preparedness to address threats as a result of terrorism, pandemic influenza and emerging infectious diseases Goal 2: Improve global public health through international collaboration including research and information sharing Goal 3: Enhance the ability of advances in science and technology to facilitate development of safe and effective biological products Goal 4: Ensure the safety of biological products Goal 5: Advance regulatory science and research Goal 6: Manage for organizational excellence and accountability. This plan describes these goals, which will guide Center decision-making and future planning. Our overarching program goals focus on Center programs while the cross-cutting goals span across organizational and program lines to support the achievement of Center program goals.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号